NEWS RELEASES

Click on the links below / download each release, where available images have been supplied in high resolution ready for public use.

Please see key media contact for further information.
All new releases on this site are available for immediate use.

If you require Oncura photography to support an article please click here.

ONCURA™ Announces Exclusive Supply and Resale Agreement with Theragenics Corporation
ONCURA™ and Theragenics Corporation Announce Distribution Agreement more >
Date Added: 14-07-2010

Prostate Cancer Guidelines Welcomed
The Prostate Brachytherapy Advisory Group welcomes the NICE Guidelines on the diagnosis and treatment of prostate cancer published 27 February , in particular, the emphasis on informed patient choice and that patients should be supported to make treatment decisions which take into account their quality of life as well as survival. more >
Date Added: 27-02-2008

Pinhole Surgery Reduces the Risks of Erectile Problems after Prostate Cancer
The 14 February is well known amongst lovers as Valentine’s Day, but it is also National `Think About Sex Day’. Unfortunately, for many men who are impotent the physical side of maintaining a sexual relationship can be both difficult and distressing. more >
Date Added: 14-02-2008

ONCURA™ signs contract with The London Clinic to support new prostate cancer service
London, 31 August 2007 – ONCURA, a leading provider of brachytherapy products, has been awarded the contract with The London Clinic – one of the UK’s most established independent hospitals – to provide radioactive seeds for their new low dose rate (LDR) brachytherapy service for the treatment of prostate cancer, one of the commonest forms of cancer in men. more >
Date Added: 31-08-2007

Leading MPs support Early Day Motion for better access to treatment for men with prostate cancer
London, 17 July 2007 – A new Early Day Motion (EDM) calling for better access to treatment for men with prostate cancer is gaining support from leading MPs in the House of Commons. Sponsored by Dr Ian Gibson MP, Chair of the All Party Parliamentary Group on Cancer at Westminster, the EDM calls for the eradication of the postcode lottery system for a treatment option known as Low Dose Rate (LDR) Brachytherapy. more >
Date Added: 17-07-2007

Medical Experts Demand Better Access to Treatment for Prostate Cancer Patients
19 June 2007, Glasgow: A group of leading healthcare professionals – The Prostate Brachytherapy Advisory Group - has called today for the eradication of the postcode lottery system for prostate cancer patients seeking a form of treatment known as low dose rate (LDR) brachytherapy. Currently, 1 in 6 patients are denied access to this proven therapy1 despite the fact that the National Institute of Health and Clinical Excellence (NICE) has approved LDR brachytherapy2 and the Department of Health has issued advice supporting increased usage.3 more >
Date Added: 19-06-2007

News

***ONCURA™ Announces Exclusive Supply and Resale Agreement with Theragenics Corporation***
> Read More

Key Media Contacts

UK
Sally Robinson:
sally@etalpr.co.uk

US
Lory Bradley
lory.bradley@ge.com

Spain
Elena Aspe
elena.aspe@ge.com

Germany
Juergen Schroeder
juergen.schroeder@ge.com

Australia
Marisa James
marisa.james@ge.com

France
Michel Aimar
michel.aimar@ge.com